Safeguarding Women’s and Children’s Health Act of 2022

12/30/2022, 4:18 AM

Safeguarding Women's and Children's Health Act of 2022

This bill imposes reporting requirements relating to abortion drugs.

The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug.

The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events.

The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.

Bill 117 HR 6702, also known as the Safeguarding Women's and Children's Health Act of 2022, aims to protect the health and well-being of women and children in the United States. The bill addresses various issues related to healthcare, including access to reproductive health services, maternal and child health, and healthcare disparities.

One key provision of the bill is to ensure that women have access to comprehensive reproductive health services, including contraception, prenatal care, and abortion services. The bill also seeks to improve maternal and child health outcomes by increasing funding for programs that support pregnant women and new mothers, such as the Maternal and Child Health Block Grant Program.

Additionally, the bill aims to address healthcare disparities by promoting health equity and reducing barriers to care for marginalized communities. This includes increasing funding for community health centers and programs that serve low-income and underserved populations. Overall, the Safeguarding Women's and Children's Health Act of 2022 is a comprehensive piece of legislation that seeks to improve the health and well-being of women and children in the United States. It addresses a range of issues related to healthcare access, reproductive health, and healthcare disparities, with the goal of ensuring that all individuals have access to the care they need to lead healthy and fulfilling lives.
Congress
117

Number
HR - 6702

Introduced on
2022-02-09

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

2/9/2022

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Safeguarding Women's and Children's Health Act of 2022

This bill imposes reporting requirements relating to abortion drugs.

The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug.

The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events.

The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.

Bill 117 HR 6702, also known as the Safeguarding Women's and Children's Health Act of 2022, aims to protect the health and well-being of women and children in the United States. The bill addresses various issues related to healthcare, including access to reproductive health services, maternal and child health, and healthcare disparities.

One key provision of the bill is to ensure that women have access to comprehensive reproductive health services, including contraception, prenatal care, and abortion services. The bill also seeks to improve maternal and child health outcomes by increasing funding for programs that support pregnant women and new mothers, such as the Maternal and Child Health Block Grant Program.

Additionally, the bill aims to address healthcare disparities by promoting health equity and reducing barriers to care for marginalized communities. This includes increasing funding for community health centers and programs that serve low-income and underserved populations. Overall, the Safeguarding Women's and Children's Health Act of 2022 is a comprehensive piece of legislation that seeks to improve the health and well-being of women and children in the United States. It addresses a range of issues related to healthcare access, reproductive health, and healthcare disparities, with the goal of ensuring that all individuals have access to the care they need to lead healthy and fulfilling lives.
Alternative Names
Official Title as IntroducedTo require more accurate reporting of abortion drug prescribing and related adverse events, and for other purposes.

Policy Areas
Health

Comments

Recent Activity

Latest Summary9/6/2022

Safeguarding Women's and Children's Health Act of 2022

This bill imposes reporting requirements relating to abortion drugs.

The Food and Drug Administration (FDA) must require health care practitioners to report (1)...


Latest Action2/10/2022
Referred to the Subcommittee on Health.